SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per-share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
REVENUES
|
$
|
40,141
|
|
|
$
|
38,188
|
|
|
$
|
33,383
|
|
Cost of revenues
|
28,739
|
|
|
26,351
|
|
|
22,272
|
|
GROSS PROFIT
|
11,402
|
|
|
11,837
|
|
|
11,111
|
|
Selling, general and administrative
|
11,168
|
|
|
12,223
|
|
|
10,812
|
|
Depreciation and amortization
|
811
|
|
|
801
|
|
|
294
|
|
OPERATING INCOME (LOSS)
|
(577
|
)
|
|
(1,187
|
)
|
|
5
|
|
OTHER INCOME (EXPENSE)
|
|
|
|
|
|
|
|
|
Interest income
|
20
|
|
|
13
|
|
|
32
|
|
Interest expense
|
(94
|
)
|
|
(115
|
)
|
|
—
|
|
TOTAL OTHER INCOME (EXPENSE)
|
(74
|
)
|
|
(102
|
)
|
|
32
|
|
INCOME (LOSS) BEFORE INCOME TAXES
|
(651
|
)
|
|
(1,289
|
)
|
|
37
|
|
INCOME TAX EXPENSE
|
|
|
|
|
|
Current
|
29
|
|
|
4
|
|
|
24
|
|
Deferred
|
(8
|
)
|
|
—
|
|
|
—
|
|
TOTAL INCOME TAX EXPENSE
|
21
|
|
|
4
|
|
|
24
|
|
NET INCOME (LOSS)
|
$
|
(672
|
)
|
|
$
|
(1,293
|
)
|
|
$
|
13
|
|
NET INCOME (LOSS) PER COMMON SHARE
|
|
|
|
|
|
|
|
|
Basic and Diluted
|
$
|
(0.04
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
0.00
|
|
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME (LOSS) PER COMMON SHARE:
|
|
|
|
|
|
|
|
|
Basic
|
16,055
|
|
|
15,949
|
|
|
15,448
|
|
Diluted
|
16,055
|
|
|
15,949
|
|
|
15,838
|
|
See accompanying notes to consolidated financial statements
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
Treasury Stock
|
|
|
|
|
|
|
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Additional Paid-
in Capital
|
|
Accumulated
Deficit
|
|
Total Stockholders’
Equity
|
Balances, June 30, 2015
|
|
15,575,041
|
|
|
$
|
156
|
|
|
(191,250
|
)
|
|
$
|
(809
|
)
|
|
$
|
24,344
|
|
|
$
|
(105
|
)
|
|
$
|
23,586
|
|
Exercise of stock options
|
|
112,425
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
312
|
|
|
—
|
|
|
313
|
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
676
|
|
|
—
|
|
|
676
|
|
Issuance of restricted stock
|
|
52,992
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
Shares repurchased
|
|
—
|
|
|
—
|
|
|
(104,365
|
)
|
|
(745
|
)
|
|
—
|
|
|
—
|
|
|
(745
|
)
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13
|
|
|
13
|
|
Balances, June 30, 2016
|
|
15,740,458
|
|
|
158
|
|
|
(295,615
|
)
|
|
(1,554
|
)
|
|
25,331
|
|
|
(92
|
)
|
|
23,843
|
|
Exercise of stock options
|
|
95,050
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
341
|
|
|
—
|
|
|
342
|
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
496
|
|
|
—
|
|
|
496
|
|
Issuance of common shares for acquisition
|
|
415,527
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
1,895
|
|
|
—
|
|
|
1,899
|
|
Issuance of restricted stock
|
|
52,992
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,293
|
)
|
|
(1,293
|
)
|
Balances, June 30, 2017
|
|
16,304,027
|
|
|
163
|
|
|
(295,615
|
)
|
|
(1,554
|
)
|
|
28,063
|
|
|
(1,385
|
)
|
|
25,287
|
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
476
|
|
|
—
|
|
|
476
|
|
Issuance of common shares for lease
|
|
20,617
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
83
|
|
|
—
|
|
|
83
|
|
Issuance of restricted stock
|
|
52,992
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(672
|
)
|
|
(672
|
)
|
Balances, June 30, 2018
|
|
16,377,636
|
|
|
$
|
164
|
|
|
(295,615
|
)
|
|
$
|
(1,554
|
)
|
|
$
|
28,621
|
|
|
$
|
(2,057
|
)
|
|
$
|
25,174
|
|
See accompanying notes to consolidated financial statements
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
|
2018
|
|
2017
|
|
2016
|
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
Net income (loss)
|
$
|
(672
|
)
|
|
$
|
(1,293
|
)
|
|
$
|
13
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
1,561
|
|
|
1,485
|
|
|
816
|
|
|
Bad debt expense
|
62
|
|
|
20
|
|
|
34
|
|
|
Non-cash lease expense
|
37
|
|
|
—
|
|
|
—
|
|
|
Loss on inventory write-down
|
—
|
|
|
—
|
|
|
17
|
|
|
Loss on disposal of property, plant and equipment
|
13
|
|
|
10
|
|
|
—
|
|
|
Stock-based compensation expense
|
476
|
|
|
496
|
|
|
676
|
|
|
Deferred tax benefit
|
(8
|
)
|
|
—
|
|
|
—
|
|
|
Changes in operating assets and liabilities, net of effects of business acquisitions:
|
|
|
|
|
|
|
|
|
|
Accounts receivable
|
1,121
|
|
|
(1,264
|
)
|
|
892
|
|
|
Inventory
|
305
|
|
|
(61
|
)
|
|
(1,055
|
)
|
|
Prepaid and other assets
|
(20
|
)
|
|
(35
|
)
|
|
(46
|
)
|
|
Accounts payable and accrued liabilities
|
29
|
|
|
125
|
|
|
(759
|
)
|
|
Deferred revenue
|
(535
|
)
|
|
(61
|
)
|
|
600
|
|
|
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
|
2,369
|
|
|
(578
|
)
|
|
1,188
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Purchase of property, plant and equipment
|
(1,212
|
)
|
|
(2,486
|
)
|
|
(1,926
|
)
|
|
Cash proceeds from sale of property, plant and equipment
|
10
|
|
|
23
|
|
|
—
|
|
|
Additions to intangible assets
|
(86
|
)
|
|
(163
|
)
|
|
—
|
|
|
Payments for business acquisitions, net of cash acquired
|
—
|
|
|
(7,314
|
)
|
|
(1,552
|
)
|
|
NET CASH USED IN INVESTING ACTIVITIES
|
(1,288
|
)
|
|
(9,940
|
)
|
|
(3,478
|
)
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options
|
—
|
|
|
342
|
|
|
313
|
|
|
Repayments of long-term debt
|
(601
|
)
|
|
(3,184
|
)
|
|
—
|
|
|
Proceeds from long-term debt
|
—
|
|
|
5,600
|
|
|
—
|
|
|
Shares repurchased
|
—
|
|
|
—
|
|
|
(745
|
)
|
|
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES
|
(601
|
)
|
|
2,758
|
|
|
(432
|
)
|
|
|
|
|
|
|
|
|
|
|
|
NET INCREASE (DECREASE) IN CASH
|
480
|
|
|
(7,760
|
)
|
|
(2,722
|
)
|
|
|
|
|
|
|
|
|
|
|
|
CASH, beginning of year
|
4,675
|
|
|
12,435
|
|
|
15,157
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH, end of year
|
$
|
5,155
|
|
|
$
|
4,675
|
|
|
$
|
12,435
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL CASH FLOW DISCLOSURES:
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
$
|
3
|
|
|
$
|
9
|
|
|
$
|
152
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid on long-term debt
|
$
|
87
|
|
|
$
|
107
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
NON-CASH INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for acquisition
|
$
|
—
|
|
|
$
|
1,899
|
|
|
$
|
—
|
|
|
Issuance of common stock for lease
|
$
|
83
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Unpaid consideration related to acquisitions
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
181
|
|
|
Transfer of equipment to inventory
|
$
|
193
|
|
|
$
|
118
|
|
|
$
|
143
|
|
|
Property, plant and equipment financed through accounts payable
|
$
|
(13
|
)
|
|
$
|
28
|
|
|
$
|
—
|
|
See accompanying notes to consolidated financial statements
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
NOTE 1 - ORGANIZATION AND BACKGROUND
Organization
: The accompanying consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation.
Business
: Sharps is a leading full-service national provider of comprehensive waste management services including medial, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System
®
), TakeAway Medication Recovery System™, MedSafe
®
, TakeAway Recycle System™,
ComplianceTRAC
SM
, SharpsTracer
®
, Sharps Secure
®
Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System
.
The Company also offers route-based pickup services in a
twenty-three (23)
state region of the South, Southeast and Northeast portions of the United States.
Concentration of Customers and Service Providers
: There is an inherent concentration of credit risk associated with accounts receivable arising from sales to major customers. For the fiscal year ended
June 30, 2018
,
one
customer represented approximately
17%
of revenues. This customer also represented approximately
13%
, or
$0.8 million
, of the total accounts receivable balance as of
June 30, 2018
. For the fiscal year ended
June 30, 2017
,
one
customer represented approximately
17%
of revenues and
10%
, or
$0.8 million
, of the total accounts receivable balance as of
June 30, 2017
. For the fiscal year ended
June 30, 2016
,
one
customer represented approximately
17%
of revenues. The Company may be adversely affected by its dependence on a limited number of high volume customers.
Currently, the majority of Sharps transportation is sourced with the United States Postal Service (“USPS”), which consists of delivering the Sharps Recovery System from the end user to the Company’s facilities. The Company also has an arrangement with United Parcel Service Inc. (“UPS”) whereby UPS transports certain of the Company’s products from the end user to the Company’s facilities. Sharps maintains relationships with multiple raw materials suppliers and vendors in order to meet customer demands and assure availability of our products and solutions. With respect to the Sharps Recovery System solutions, the Company owns proprietary molds and dies and utilizes several contract manufacturers for the production of the primary raw materials. Sharps believes that alternative suitable contract manufacturers are readily available to meet the production specifications of our products and solutions. The Company utilizes national suppliers for the majority of the raw materials used in our other products and solutions and international suppliers for Pitch-It IV Poles.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Revenue Recognition
: The Company recognizes revenue, net of applicable sales tax, when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory ("VMI") program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the fiscal years ended
June 30, 2018
,
2017
and
2016
, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of
$2.4 million
,
$3.4 million
and
$3.2 million
, respectively. As of
June 30, 2018
and
2017
,
$2.1 million
and
$2.7 million
, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.
Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to
three
separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service. For Mailbacks that are part of a VMI program, there is an additional element, or unit of measure, for outbound transportation.
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities.
Revenue for the sale of the compliance and container system is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.
In May 2014 and as subsequently amended, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. See "Recently Issued Accounting Standards" as follows for more details about the impact of this new accounting standard.
Business Combinations
: The Company includes the results of operations of the businesses that are acquired as of the respective dates of acquisition. The Company allocates the fair value of the purchase price of acquisitions to the assets acquired and liabilities assumed based on their estimated fair values. The Company estimates and records the fair value of purchased intangible assets, which primarily consists of customer relationships, trade-names, and non-competes. The excess of the fair value of the purchase price over the fair values of these identifiable assets, both tangible and intangible, and liabilities is recorded as goodwill.
Income Taxes
: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. A valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.
The Company is subject to income taxes in the United States and in numerous state tax jurisdictions. Significant judgment is required in evaluating the Company’s tax positions and determining its provision for income taxes. The Company accounts for uncertain tax positions in accordance with FASB ASC 740, which prescribes the minimum recognition threshold a tax position taken or expected to be taken in a tax return is required to meet before being recognized in the financial statements. The Company has not recognized any material uncertain tax positions for the years ended
June 30, 2018
,
2017
and
2016
. Tax return filings which are subject to review by federal and state tax authorities by jurisdiction are as follows:
|
|
•
|
United States – fiscal years ended June 30,
2015
and after
|
|
|
•
|
State of Texas – fiscal years ended June 30,
2013
and after
|
|
|
•
|
State of Georgia – fiscal years ended June 30,
2015
and after
|
|
|
•
|
State of Pennsylvania – fiscal years ended June 30,
2015
and after
|
|
|
•
|
Other States – fiscal years ended June 30,
2014
and after
|
None of the Company’s federal or state tax returns are currently under examination. The Company records income tax related interest and penalties, if applicable, as a component of the provision for income tax expense. However, there were
no
such amounts recognized in the consolidated statements of operations in
2018
,
2017
and
2016
.
Accounts Receivable
: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third-party collection agency. The Company has a history of minimal uncollectible accounts. See rollforward of allowance activity below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for Doubtful
Accounts
|
|
Balance
Beginning
of Year
|
|
Charges to
Expense
|
|
Write-offs
/Recoveries
|
|
Balance End
of Year
|
|
|
|
|
|
|
|
|
|
2018
|
|
$
|
78
|
|
|
$
|
62
|
|
|
$
|
(38
|
)
|
|
$
|
102
|
|
2017
|
|
$
|
63
|
|
|
$
|
20
|
|
|
$
|
(5
|
)
|
|
$
|
78
|
|
2016
|
|
$
|
34
|
|
|
$
|
34
|
|
|
$
|
(5
|
)
|
|
$
|
63
|
|
Stock-Based Compensation:
Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the requisite service period (generally the vesting period of the equity grant). Total stock-based compensation expense for the fiscal years ended
June 30, 2018
,
2017
and
2016
are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
Stock-based compensation expense included in:
|
|
|
|
|
|
Cost of revenue
|
$
|
43
|
|
|
$
|
41
|
|
|
$
|
31
|
|
Selling, general and administrative
|
433
|
|
|
455
|
|
|
645
|
|
Total
|
$
|
476
|
|
|
$
|
496
|
|
|
$
|
676
|
|
The Company estimates the fair value of restricted stock awards based on the closing price of the Company’s common stock on the date of the grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term, the expected volatility of the Company’s stock over the option’s expected term, the risk free interest rate over the option’s expected term and the Company’s expected annual dividend yield. The risk free interest rate is derived using the U.S. Treasury yield curve in effect at date of grant. Volatility, expected life and dividend yield are based on historical experience and activity.
The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
Weighted average risk-free interest rate
|
1.2
|
%
|
|
1.1
|
%
|
|
1.0
|
%
|
Weighted average expected volatility
|
48
|
%
|
|
47
|
%
|
|
45
|
%
|
Weighted average expected life (in years)
|
3.03
|
|
|
5.15
|
|
|
4.56
|
|
Dividend yield
|
—
|
|
|
—
|
|
|
—
|
|
The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life.
Cash
: The Company maintains funds in bank accounts that, at times, may exceed the limit insured by the Federal Deposit Insurance Corporation (“FDIC”). The risk of loss attributable to these uninsured balances is mitigated by depositing funds only in high credit quality financial institutions. The Company has not experienced any losses in such accounts.
Inventory
: Inventory consists primarily of raw materials and finished goods held for sale and are stated at the lower of cost or net realizable value using the average cost method. The Company periodically reviews the value and classification of items in inventory and provides write-downs or write-offs of inventory based on its assessment of physical deterioration, obsolescence, changes in
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
price levels and other causes. At
June 30, 2018
, total inventory was
$4.0 million
of which
$2.7 million
was finished goods, and
$1.3 million
was raw materials. At
June 30, 2017
, total inventory was
$4.1 million
of which
$2.8 million
was finished goods, and
$1.3 million
was raw materials. There were
no
write-downs of inventory for the fiscal years ended
June 30, 2018
and
2017
. Total write-downs for the fiscal year ended
June 30, 2016
were
$17,000
and were included in cost of goods sold.
Property, Plant and Equipment
: Property, plant and equipment, including third party software and implementation costs, is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets. Additions, improvements and renewals significantly adding to the asset value or extending the life of the asset are capitalized. Ordinary maintenance and repairs, which do not extend the physical or economic life of the property or equipment, are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in the results of operations for the period.
Computer and software development costs, which include costs of computer software developed or obtained for internal use, all programming, implementation and costs incurred with developing internal-use software, are capitalized during the development project stage. External direct costs of materials and services consumed in developing or obtaining internal-use computer software are capitalized.
The Company expenses costs associated with developing or obtaining internal-use software during the preliminary project stage. Training and maintenance costs associated with system changes or internal-use software are expensed as incurred. Additionally, the costs of data cleansing, reconciliation, balancing of old data to the new system, creation of new/additional data and data conversion costs are expensed as incurred.
Goodwill and Other Identifiable Intangible Assets:
Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit’s goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge. The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was
no
impairment during the years ended
June 30, 2018
,
2017
and
2016
.
Intangible Assets
: Intangible assets consist of (i) acquired customer relationships, (ii) permit costs related to the Company’s treatment facilities and transfer stations, and (iii)
eleven
patents (
two
acquired in June 1998,
one
in November 2003,
one
in January 2012,
two
in April 2012,
one
in August 2012,
one
in September 2012,
one
in December 2012,
one
in November 2013 and
one
in January 2014), and (iv) defense costs related to certain existing patents.
Accrued Liabilities
: The components of Accrued Liabilities on the balance sheet as of
June 30, 2018
and
2017
are as follows:
|
|
|
|
|
|
|
|
|
|
As of June 30,
|
|
2018
|
|
2017
|
Accrued payroll
|
$
|
389
|
|
|
$
|
322
|
|
Customer-related payables
|
334
|
|
|
226
|
|
Accrued rebates
|
327
|
|
|
297
|
|
Other
|
1,011
|
|
|
955
|
|
Total
|
$
|
2,061
|
|
|
$
|
1,800
|
|
Shipping and Handling Fees and Costs
: The Company records amounts billed to customers for shipping and handling as revenue. Costs incurred by the Company for shipping and handling have been classified as cost of revenues.
Additional Product Related Costs
: The Company records inbound shipping, purchasing and receiving costs, inspection costs, warehousing costs and other product related costs as cost of revenues.
Advertising Costs
: Advertising costs are charged to expenses when incurred and totaled
$0.7 million
,
$0.8 million
and
$0.6 million
for the fiscal years ended
June 30, 2018
,
2017
and
2016
, respectively.
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
Research and Development Costs
: Research and development costs are charged to expense when incurred. Research activities represent an important part of the Company’s business and include both internal labor costs and payments to third parties related to the processes of discovering, testing and developing new products, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch of new products and services. Research and development expenses paid to third parties totaled less than
$0.1 million
for each of the fiscal years ended
June 30, 2018
,
2017
and
2016
.
Realization of Long-lived Assets
: The Company evaluates the recoverability of property, plant and equipment and intangible or other assets if facts and circumstances indicate that any of those assets might be impaired. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset’s carrying amount to determine if a write-down to fair value is necessary.
No
impairment loss was recognized during the years ended
June 30, 2018
,
2017
and
2016
.
Employee Benefit Plans
: In addition to group health-related benefits, the Company maintains a 401(k) employee savings plan available to all full-time employees. The Company matches a portion of employee contributions with cash (
25%
of employee contribution up to
6%
). Company contributions to the 401(k) plan were less than
$0.1 million
in each of the fiscal years ended
June 30, 2018
,
2017
and
2016
, respectively and are included in selling, general and administrative expenses. For purposes of the group health benefit plan and beginning February 1, 2016, the Company self-insures an amount equal to the excess of the employees’ deductible (range from
$2,500
for each individual and family member covered) up to the amount by which the third-party insurance coverage begins (ranges from
$2,500
for individual up to
$10,000
for family coverage). The amount of liability at
June 30, 2018
and
2017
was less than
$0.1 million
and is included in accrued liabilities. The Company also has an incentive plan for executives of the Company, which provides for performance based cash and stock-based compensation awards.
No
expense was recognized during the years ended
June 30, 2018
,
2017
and
2016
for cash awards pursuant to the plan.
Net Income (Loss) Per Share
: Basic earnings per share excludes dilution and is determined by dividing income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution that could occur if securities and other contracts to issue common stock were exercised or converted into common stock.
Fair Value of Financial Instruments
: The Company considers the fair value of cash, accounts receivable and accounts payable to approximate their carrying values at year-end due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.
Fair Value Measurements
: The Company employs a hierarchy which prioritizes the inputs used to measure recurring fair value into three distinct categories based on the lowest level of input that is significant to the fair value measurement. Our methodology for categorizing assets and liabilities that are measured at fair value pursuant to this hierarchy gives the highest priority to unadjusted quoted prices in active markets and the lowest levels to unobservable inputs, summarized as follows:
|
|
•
|
Level 1 – Quoted prices in active markets for identical assets or liabilities.
|
|
|
•
|
Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).
|
|
|
•
|
Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value).
|
We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the years ended
June 30, 2017
and
2016
utilized level 3 inputs.
Segment Reporting
: The Company operates in a single segment, focusing on developing cost-effective management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators.
Use of Estimates
: The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting period. The Company uses estimates to determine many reported amounts, including but not limited to allowance for doubtful accounts, recoverability of long-lived assets and intangibles, useful lives used in depreciation and amortization, income taxes and valuation allowances, stock-based compensation, fair values of assets and liabilities acquired in business combinations, selling price used in multiple-deliverable arrangements and return rates used to estimate the percentage of container systems sold that will not be returned. Actual results could differ from these estimates.
Reclassification of Prior Year Presentation in the Consolidated Statements of Cash Flows
: Certain prior year amounts have been reclassified for consistency with the current year presentation in the Consolidated Statements of Cash Flows. The change in classification does not affect previously reported cash flows from operating activities, investing activities or financing activities in the Consolidated Statements of Cash Flows.
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
Recently Issued Accounting Standards
: In May 2014 and as subsequently amended, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. Companies have an option to use either a full retrospective approach or a modified retrospective approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company has substantially completed its analysis to evaluate the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures which included identifying the material revenue streams and reviewing a representative sample of contracts. As a result of the analysis, the Company determined the following:
|
|
•
|
The transportation and treatment performance obligations related to the mail back and unused medication solutions, which were historically accounted for as separate performance obligations, will be accounted for as a single performance obligation under the amended revenue recognition guidance. The impact of this is not expected to be material.
|
|
|
•
|
Certain costs associated with obtaining long-term contracts with customers will be capitalized and amortized over the expected economic life of the contract in future period. The impact of this is not expected to be material.
|
|
|
•
|
The new guidance may change the timing of revenue recognition and related expense on certain of the Company’s vendor managed inventory contracts. We are currently finalizing our analysis but expect the cumulative adjustment to be less than
$0.4 million
.
|
The Company intends to adopt the standard using the modified retrospective approach, which involves retrospectively adopting the standard by recording a cumulative effect adjustment to all uncompleted contracts at July 1, 2018.
In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.
NOTE 3 – PROPERTY, PLANT AND EQUIPMENT
At
June 30, 2018
and
2017
, property, plant and equipment consisted of the following (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
|
Useful Life
|
|
2018
|
|
2017
|
Furniture and fixtures
|
|
3 to 5 years
|
|
$
|
245
|
|
|
$
|
260
|
|
Plant and equipment
|
|
3 to 17 years
|
|
8,241
|
|
|
7,975
|
|
Manufacturing
|
|
15 years
|
|
169
|
|
|
220
|
|
Computers and software
|
|
3 to 5 years
|
|
2,064
|
|
|
2,246
|
|
Leasehold improvements
|
|
Life of Lease
|
|
2,729
|
|
|
2,681
|
|
Land
|
|
|
|
19
|
|
|
19
|
|
Construction-in-progress
|
|
|
|
716
|
|
|
347
|
|
|
|
|
|
14,183
|
|
|
13,748
|
|
Less: accumulated depreciation
|
|
|
|
7,611
|
|
|
7,205
|
|
Net property, plant and equipment
|
|
|
|
$
|
6,572
|
|
|
$
|
6,543
|
|
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
Total depreciation expense in the fiscal years ended
June 30, 2018
,
2017
and
2016
was
$1.0 million
,
$0.9 million
and
$0.7 million
, respectively. Depreciation expense included in cost of revenues in the fiscal years ended
2018
,
2017
and
2016
was
$0.8 million
,
$0.7 million
and
$0.5 million
, respectively.
NOTE 4 – INCOME TAXES
The components of income tax expense (benefit) are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
Current:
|
|
|
|
|
|
Federal
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
State
|
29
|
|
|
4
|
|
|
24
|
|
Total Current
|
$
|
29
|
|
|
$
|
4
|
|
|
$
|
24
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
Federal
|
$
|
(8
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
State
|
—
|
|
|
—
|
|
|
—
|
|
Total Deferred
|
(8
|
)
|
|
—
|
|
|
—
|
|
Net Income Tax Expense
|
$
|
21
|
|
|
$
|
4
|
|
|
$
|
24
|
|
The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended
June 30, 2018
,
2017
and
2016
is as follows
:
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
Statutory rate
|
27.6
|
%
|
|
34.0
|
%
|
|
34.0
|
%
|
State income taxes, net
|
(3.7
|
)%
|
|
(4.5
|
)%
|
|
(18.6
|
)%
|
Impact of 2017 tax reform
|
(107.0
|
)%
|
|
—
|
%
|
|
—
|
%
|
Meals and entertainment
|
(1.8
|
)%
|
|
(1.5
|
)%
|
|
38.7
|
%
|
Stock-based compensation
|
22.6
|
%
|
|
—
|
%
|
|
—
|
%
|
AMT and research and development credits
|
22.4
|
%
|
|
—
|
%
|
|
(218.9
|
)%
|
Other
|
(2.0
|
)%
|
|
0.2
|
%
|
|
1.5
|
%
|
Effective rate before valuation allowance
|
(41.9
|
)%
|
|
28.2
|
%
|
|
(163.3
|
)%
|
Change in valuation allowance
|
38.7
|
%
|
|
(28.5
|
)%
|
|
228.2
|
%
|
Effective tax rate
|
(3.2
|
)%
|
|
(0.3
|
)%
|
|
64.9
|
%
|
The statutory rate for the year ended
June 30, 2018
is a blended rate which was calculated based on the Company's fiscal year and the date that the tax rate changes were effective.
A valuation allowance has been recorded to reduce the Company’s net deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The establishment of valuation allowances requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets.
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
At
June 30, 2018
and
2017
, the significant components of deferred tax assets and liabilities are approximated as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
2018
|
|
2017
|
Deferred tax assets relating to:
|
|
Stock-based compensation
|
$
|
283
|
|
|
$
|
398
|
|
AMT and research and development credits
|
668
|
|
|
523
|
|
Deferred rent
|
58
|
|
|
77
|
|
Inventory
|
147
|
|
|
211
|
|
Professional fees
|
91
|
|
|
155
|
|
Accrued vacation
|
31
|
|
|
43
|
|
Accounts receivable allowance
|
26
|
|
|
49
|
|
Contribution carryovers
|
13
|
|
|
12
|
|
Net operating loss carryforwards
|
1,153
|
|
|
1,443
|
|
Total deferred tax assets
|
2,470
|
|
|
2,911
|
|
Deferred tax liabilities related to depreciable and amortizable assets
|
(587
|
)
|
|
(783
|
)
|
Net deferred tax assets before valuation allowance
|
1,883
|
|
|
2,128
|
|
Valuation allowance
|
(1,875
|
)
|
|
(2,128
|
)
|
Net deferred tax assets
|
$
|
8
|
|
|
$
|
—
|
|
At
June 30, 2018
, the Company had net operating loss carryforwards of
$5.3 million
, of which
$4.7 million
will expire, if unused, between
June 30, 2032
and
June 30, 2037
. At
June 30, 2018
, the Company had various tax credit carryforwards of
$0.7 million
, of which
$0.4 million
will expire beginning on
June 30, 2030
and
$0.3 million
related to alternative minimum tax credits which will be refunded as described below.
The Tax Cuts and Jobs Act of 2017, enacted on December 22, 2017, contains significant changes to U.S. tax law, including lowering the U.S. corporate income tax rate to
21%
and repeal of the corporate alternative minimum tax for tax years beginning on or after January 1, 2018. Other provisions in the 2017 tax reform such as interest deductibility, changes to executive compensation plans, full expensing provisions for business assets, other new minimum taxes and international taxation modifications are not expected to have material implications to the Company's financial statements. Also, in December 2017, the SEC issued guidance on accounting for tax effects of the 2017 tax reform which provides a measurement period that should not extend beyond one year from the enactment date for companies to complete the applicable accounting. In accordance with the guidance, a company must reflect the income tax effects of those aspects for which the accounting under the guidance is complete. To the extent that a company’s accounting for certain income tax effects is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate to be included in the financial statements. While we are able to make reasonable estimates of the impact of the reduction in corporate rate and the repeal of the corporate alternative minimum tax for tax years beginning on or after January 1, 2018, the final impact of the 2017 tax reform may differ from these estimates, due to, among other things, changes in our interpretations and assumptions, additional guidance that may be issued by the Internal Revenue Service ("IRS"), and actions we may take. We are continuing to gather additional information to determine the final impact.
The Company is required to recognize the impacts of the rate change on its deferred tax assets and liabilities in the period enacted. However, as the Company has a full valuation allowance on its net deferred tax asset, any deferred tax recognized due to the change in rate will be offset with a change in the valuation allowance. Therefore, there was no overall impact to the financial statements in the year ended June 30, 2018 due to this change in rate. However, the repeal of the corporate alternative minimum tax provides for existing alternative minimum tax credit carryovers to be refunded beginning in 2018 and available to offset deferred tax liabilities related to indefinite lived assets as described below. As such, most of the valuation allowance in place at June 30, 2018 related to these credits has been released on a provisional basis and a deferred asset recorded for the expected benefit in future years. During the year ended
June 30, 2018
, the Company recorded an
$8,000
deferred tax asset in Other Assets on the balance sheet, representing the net benefit of remeasuring its deferred tax assets for recoverable alternative minimum tax credits pursuant to the 2017 tax reform in the amount of
$245,000
offset by deferred tax liabilities related to indefinite lived assets, such as goodwill, in the amount of
$237,000
, which cannot be used as a source of future taxable income in evaluating the need for a valuation allowance against deferred tax assets. The Company's remaining net deferred tax assets continue to be fully offset by a valuation allowance. The Company's gross deferred tax assets and the offsetting valuation allowance decreased on a provisional basis by approximately
$0.7 million
as a result of the reduction of the U.S. tax rate to
21%
.
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
NOTE 5 - NOTES PAYABLE AND LONG-TERM DEBT
On March 29, 2017, the Company entered into to a credit agreement with a commercial bank which was subsequently amended on June 29, 2018 to extend the maturity date by
two
years (“Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a
$14.0 million
credit facility, the proceeds of which may be utilized as follows: (i)
$6.0 million
for working capital, letters of credit (up to
$2.0 million
) and general corporate purposes and (ii)
$8.0 million
for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the Company’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to
80%
of eligible accounts receivable plus the lesser of (i)
50%
of eligible inventory and (ii)
$3.0 million
. Advances under the acquisition portion of the credit facility are limited to
75%
of the purchase price of an acquired company and convert to a
five
-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a)
zero
percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of
2.5%
. The LIBOR Margin may increase to as high as
3.0%
depending on the Company’s cash flow leverage ratio. The interest rate as of
June 30, 2018
was approximately
4.63%
. The Company pays a fee of
0.25%
per annum on the unused amount of the credit facility.
At
June 30, 2018
, long-term debt consisted of the following (in thousands):
|
|
|
|
|
Non-interest bearing, unsecured note payable assumed in acquisition (See Note 12), monthly payments of $7; maturing September 2018.
|
$
|
20
|
|
|
|
|
Term loan, bearing interest at 4.63%, monthly payments of $43; maturing March 2022.
|
1,982
|
|
|
|
|
Total long-term debt
|
2,002
|
|
Less: current portion
|
537
|
|
Long-term debt, net of current portion
|
$
|
1,465
|
|
The Company has availability under the Credit Agreement of
$12.0 million
(
$6.0 million
for the working capital and
$6.0 million
for the acquisitions) as of
June 30, 2018
. The Company also has
$40,000
in letters of credit outstanding as of
June 30, 2018
.
The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain a maximum cash flow leverage ratio of no more than
3.0
to 1.0 and a minimum debt service coverage ratio of not less than
1.15
to 1.00. The Credit Agreement, which expires on March 29, 2021 for the working capital portion of the Credit Agreement, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders. The leverage ratio covenant may limit the amount available under the Credit Agreement. The Company was in compliance with all the financial covenants under the Credit Agreement as of June 30, 2018.
Payments due on long-term debt over the five years subsequent to
June 30, 2018
are as follows (in thousands):
|
|
|
|
|
Twelve Months Ending June 30,
|
|
2019
|
$
|
537
|
|
2020
|
517
|
|
2021
|
517
|
|
2022
|
431
|
|
|
$
|
2,002
|
|
NOTE 6 - EQUITY TRANSACTIONS
On January 7, 2013, the Company announced that its Board of Directors approved a stock repurchase program effective January 3, 2013, authorizing the Company to repurchase in the aggregate up to
$3 million
of its outstanding common stock over a
two
-year period. On March 5, 2015, the Board approved a
two
-year extension of the stock repurchase program through January 1, 2017. The program has not been extended. During the years ended June 30,
2018
,
2017
and
2016
, shares were repurchased as follows:
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
|
|
|
|
|
|
Shares repurchased
|
—
|
|
|
—
|
|
|
104,365
|
|
Cash paid for shares repurchased (in thousands)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
745
|
|
Average price paid per share
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
7.14
|
|
Total shares repurchased under the program are
295,615
shares at a cost of
$1.6 million
.
During the year ended June 30,
2018
, the Company issued
20,617
shares of common stock as a portion of consideration for a third-party lease agreement. The shares were issued at
$4.00
per share based on the closing price on the date of grant. This issuance was exempt from registration pursuant to Section 4(a)(2) of the Securities Act. Non-cash expense recorded during the year ended June 30,
2018
was
$37,000
. The remaining cost of
$46,000
will be amortized over the life of the lease and is included in Prepaid and Other Current Assets or Other Assets on the balance sheet.
NOTE 7 - STOCK BASED COMPENSATION
The Company sponsors the Sharps Compliance Corp. 2010 Stock Plan (the “2010 Plan”) covering employees, consultants and non-employee directors. The 2010 Plan provides for the granting of stock-based compensation (stock options or restricted stock) of up to
3,000,000
shares of the Company’s common stock of which
933,153
options and restricted shares are outstanding as of June 30,
2018
. Options granted generally vest over a period of
four
years and expire
seven
years after the date of grant. Restricted stock generally vests over
one
year. As of
June 30, 2018
, there were
1,453,649
options available for grant under the 2010 Plan.
The summary of activity for all restricted stock during the fiscal years ended
June 30, 2018
,
2017
and
2016
is presented in the table below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
|
|
|
|
|
|
Unvested at beginning of the year
|
13
|
|
|
13
|
|
|
13
|
|
Granted
|
53
|
|
|
53
|
|
|
53
|
|
Vested
|
(53
|
)
|
|
(53
|
)
|
|
(53
|
)
|
Unvested at end of the year
|
13
|
|
|
13
|
|
|
13
|
|
The weighted average fair value per share of restricted stock granted during the fiscal years ended
June 30, 2018
,
2017
and
2016
was
$4.17
,
$4.38
and
$8.00
, respectively. The weighted average fair value per share of restricted stock which vested during the fiscal years ended
June 30, 2018
,
2017
and
2016
was
$4.22
,
$5.29
and
$7.07
, respectively.
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
The summary of activity for all stock options during the fiscal years ended
June 30, 2018
,
2017
and
2016
is presented in the table below (in thousands except per share amounts):
|
|
|
|
|
|
|
|
|
Options
Outstanding
|
|
Weighted
Average
Exercise
Price
|
Options Outstanding at June 30, 2015
|
1,375
|
|
|
$
|
4.49
|
|
Granted
|
45
|
|
|
$
|
6.62
|
|
Exercised
|
(112
|
)
|
|
$
|
2.77
|
|
Forfeited or canceled
|
(18
|
)
|
|
$
|
5.99
|
|
|
|
|
|
Options Outstanding at June 30, 2016
|
1,290
|
|
|
$
|
4.69
|
|
Granted
|
38
|
|
|
$
|
4.55
|
|
Exercised
|
(95
|
)
|
|
$
|
3.60
|
|
Forfeited or canceled
|
(368
|
)
|
|
$
|
5.32
|
|
|
|
|
|
Options Outstanding at June 30, 2017
|
865
|
|
|
$
|
4.53
|
|
Granted
|
137
|
|
|
$
|
4.79
|
|
Forfeited or canceled
|
(82
|
)
|
|
$
|
4.50
|
|
|
|
|
|
Options Outstanding at June 30, 2018
|
920
|
|
|
$
|
4.57
|
|
|
|
|
|
Options Exercisable at June 30, 2018
|
634
|
|
|
$
|
4.46
|
|
The following table summarizes information about stock options outstanding as of
June 30, 2018
(in thousands except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
Range of Exercise
Price
|
|
Outstanding as of June 30, 2018
|
|
Weighted
Average
Remaining
Life
(in Years)
|
|
Weighted
Average
Exercise
Price
|
|
|
|
|
|
|
|
2.51 - $3.50
|
|
41
|
|
|
1.49
|
|
$
|
2.95
|
|
3.51 - $5.50
|
|
748
|
|
|
3.27
|
|
$
|
4.42
|
|
5.51 - $7.50
|
|
131
|
|
|
3.82
|
|
$
|
5.97
|
|
|
|
920
|
|
|
|
|
$
|
4.57
|
|
The following table summarizes information about stock options exercisable as of
June 30, 2018
(in thousands except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Exercisable
|
Range of Exercise
Price
|
|
Exercisable as of June 30, 2018
|
|
Weighted
Average
Remaining
Life
(in Years)
|
|
Weighted
Average
Exercise
Price
|
|
|
|
|
|
|
|
2.51 - $3.50
|
|
41
|
|
|
1.49
|
|
$
|
2.95
|
|
3.51 - $5.50
|
|
502
|
|
|
2.35
|
|
$
|
4.32
|
|
5.51 - $7.50
|
|
91
|
|
|
3.79
|
|
$
|
5.90
|
|
|
|
634
|
|
|
|
|
$
|
4.46
|
|
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
As of June 30.
2018
, there was
$0.3 million
of stock option and restricted stock compensation expense related to non-vested awards. This expense is expected to be recognized over a weighted average period of
2.3 years
.
NOTE 8 - COMMITMENTS AND CONTINGENCIES
Operating Leases:
The Company operates in a number of locations across the U.S. including space for corporate offices in Houston, Texas. Sharps has manufacturing, assembly, storage, distribution and warehousing operations as well as
two
(2) fully-permitted facilities that house our processing and treatment operations. The Company owns
one
processing and treatment facility and leases all other spaces. The Company also leases a number of trucks and office equipment. The leases expire between fiscal years
2019
to
2024
with options to renew ranging from
1
years to
5
years.
Rent expense for the fiscal years ended
June 30, 2018
,
2017
and
2016
was
$2.0 million
,
$1.5 million
and
$0.9 million
, respectively. Future minimum lease payments under non-cancelable operating leases as of
June 30, 2018
are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
Operating lease obligations
|
$
|
2,166
|
|
|
$
|
1,903
|
|
|
$
|
1,165
|
|
|
$
|
414
|
|
|
$
|
71
|
|
|
$
|
17
|
|
Performance Bonds:
The Company utilizes performance bonds to support operations based on certain state requirements. At
June 30, 2018
, the Company had performance bonds outstanding covering financial assurance up to
$0.7 million
.
Other
:
From time to time, the Company is involved in legal proceedings and litigation in the ordinary course of business. In the opinion of management, the outcome of such matters is not anticipated to have a material adverse effect on the Company’s consolidated financial position or consolidated results of operations.
NOTE 9 - EARNINGS PER SHARE
Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method.
The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material.
The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30,
|
|
2018
|
|
2017
|
|
2016
|
|
|
|
|
|
|
Net income (loss), as reported
|
$
|
(672
|
)
|
|
$
|
(1,293
|
)
|
|
$
|
13
|
|
|
|
|
|
|
|
Weighted average common shares outstanding
|
16,055
|
|
|
15,949
|
|
|
15,448
|
|
Effect of dilutive stock options
|
—
|
|
|
—
|
|
|
390
|
|
Weighted average diluted common shares outstanding
|
16,055
|
|
|
15,949
|
|
|
15,838
|
|
|
|
|
|
|
|
Net income (loss) per common share
|
|
|
|
|
|
|
|
|
Basic and diluted
|
$
|
(0.04
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
0.00
|
|
|
|
|
|
|
|
Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive
|
402
|
|
|
304
|
|
|
137
|
|
NOTE 10 – GOODWILL AND INTANGIBLE ASSETS
At
June 30, 2018
and
2017
, intangible assets consisted of the following (in thousands):
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
|
2018
|
|
2017
|
|
Estimated
Useful Lives
|
Original
Amount
|
|
Accumulated
Amortization
|
|
Net
Amount
|
|
Original
Amount
|
|
Accumulated
Amortization
|
|
Net
Amount
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer relationships
|
7 years
|
$
|
3,007
|
|
|
$
|
(919
|
)
|
|
$
|
2,088
|
|
|
$
|
3,007
|
|
|
$
|
(490
|
)
|
|
$
|
2,517
|
|
Permits
|
6 - 15 years
|
1,459
|
|
|
(390
|
)
|
|
1,069
|
|
|
1,373
|
|
|
(288
|
)
|
|
1,085
|
|
Patents
|
5 - 17 years
|
383
|
|
|
(278
|
)
|
|
105
|
|
|
383
|
|
|
(264
|
)
|
|
119
|
|
Tradename
|
7 years
|
270
|
|
|
(77
|
)
|
|
193
|
|
|
270
|
|
|
(39
|
)
|
|
231
|
|
Non-compete
|
5 years
|
117
|
|
|
(47
|
)
|
|
70
|
|
|
117
|
|
|
(23
|
)
|
|
94
|
|
Total intangible assets, net
|
|
$
|
5,236
|
|
|
$
|
(1,711
|
)
|
|
$
|
3,525
|
|
|
$
|
5,150
|
|
|
$
|
(1,104
|
)
|
|
$
|
4,046
|
|
During the years ended
June 30, 2018
,
2017
and
2016
amortization expense was
$0.6 million
,
$0.6 million
and
$0.1 million
, respectively.
The changes in the carrying amount of goodwill since
June 30, 2016
was as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2018
|
|
2017
|
Beginning Balance
|
$
|
6,735
|
|
|
$
|
1,039
|
|
Goodwill Acquired
|
—
|
|
|
5,696
|
|
Ending Balance
|
$
|
6,735
|
|
|
$
|
6,735
|
|
As of
June 30, 2018
, future amortization of intangible assets is as follows (in thousands):
|
|
|
|
|
Year Ending June 30,
|
|
2019
|
$
|
617
|
|
2020
|
621
|
|
2021
|
620
|
|
2022
|
595
|
|
2023
|
534
|
|
Thereafter
|
538
|
|
|
$
|
3,525
|
|
NOTE 11 – REVENUES BY SOLUTION
The components of revenues by solution are as follows (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30,
|
|
2018
|
|
% Total
|
|
2017
|
|
% Total
|
|
2016
|
|
% Total
|
REVENUES BY SOLUTION:
|
|
|
|
|
|
|
|
|
|
|
|
Mailbacks
|
$
|
21,786
|
|
|
54.3
|
%
|
|
$
|
24,135
|
|
|
63.2
|
%
|
|
$
|
23,743
|
|
|
71.1
|
%
|
Route-based pickup services
|
7,492
|
|
|
18.7
|
%
|
|
6,348
|
|
|
16.6
|
%
|
|
2,061
|
|
|
6.2
|
%
|
Unused medications
|
5,907
|
|
|
14.7
|
%
|
|
3,377
|
|
|
8.8
|
%
|
|
3,531
|
|
|
10.6
|
%
|
Third party treatment services
|
891
|
|
|
2.2
|
%
|
|
413
|
|
|
1.1
|
%
|
|
258
|
|
|
0.8
|
%
|
Other
(1)
|
4,065
|
|
|
10.1
|
%
|
|
3,915
|
|
|
10.3
|
%
|
|
3,790
|
|
|
11.3
|
%
|
Total revenues
|
$
|
40,141
|
|
|
100.0
|
%
|
|
$
|
38,188
|
|
|
100.0
|
%
|
|
$
|
33,383
|
|
|
100.0
|
%
|
|
|
(1)
|
The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.
|
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
NOTE 12 – ACQUISITIONS
Effective July 17, 2015, the Company acquired Alpha Bio/Med Services LLC, a route-based pickup service located in Pennsylvania for total cash consideration of
$0.7 million
.
The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands):
|
|
|
|
|
Accounts receivable
|
$
|
51
|
|
Fixed assets
|
70
|
|
Intangibles
|
267
|
|
Goodwill
|
413
|
|
Accounts payable and accrued liabilities
|
(101
|
)
|
Total purchase price
|
$
|
700
|
|
Effective on December 14, 2015, the Company acquired Bio-Team Mobile LLC, a route-based pickup service located in Pennsylvania for total cash consideration of
$1.0 million
.
The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands):
|
|
|
|
|
Accounts receivable
|
$
|
42
|
|
Fixed assets
|
68
|
|
Intangibles
|
313
|
|
Goodwill
|
626
|
|
Accounts payable and accrued liabilities
|
(16
|
)
|
Total purchase price
|
$
|
1,033
|
|
Effective July 1, 2016, the Company acquired Citiwaste, LLC (“Citiwaste”), a route-based pickup service located in New York, which is in the business of medical, pharmaceutical and hazardous waste management primarily in the healthcare industry. The purchase price consisted of
$7.0 million
in cash (
$3.0 million
of which was borrowed under the acquisition portion of its Credit Agreement),
415,527
shares of common stock of the Company (the “Common Stock Consideration”) valued at
$1.9 million
, and a lease obligation paid to the seller for
$0.1 million
for a total consideration of
$9.0 million
. The Company held shares of the Common Stock Consideration in escrow for the
one
-year period to cover indemnification obligations of the sellers under the purchase agreement which were released on
June 30, 2017
.
For the year ended
June 30, 2017
, the Company recognized approximately
$3.6 million
in revenues related to the operations of Citiwaste.
The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands):
|
|
|
|
|
Cash
|
$
|
5
|
|
Accounts receivable
|
495
|
|
Fixed assets
|
30
|
|
Intangibles
|
3,357
|
|
Goodwill
|
5,696
|
|
Accounts payable and accrued liabilities
|
(356
|
)
|
Debt assumed
|
(187
|
)
|
Total purchase price
|
$
|
9,040
|
|
The Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the consolidated statements of operations as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve-Months Ended
June 30,
|
|
2018
|
|
2017
|
|
2016
|
|
|
|
|
|
|
Acquisition-related expenses
|
$
|
—
|
|
|
$
|
702
|
|
|
$
|
190
|
|
SHARPS COMPLIANCE CORP. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2018, 2017 and 2016
The results of operations of the acquired business have been included in the consolidated statements of operations from the date of acquisition. Pro forma results of operations for Alpha Bio/Med Services and Bio-Team Mobile are not presented because the pro forma effects, individually and in the aggregate, are not material to the Company’s consolidated results of operations. The goodwill recorded for the Alpha Bio/Med Services, Bio-Team Mobile, and Citiwaste acquisitions will be deductible for income taxes.
The goodwill recognized for the acquisitions since July 1, 2015 is attributable to expected revenue synergies generated by the integration of our products and services with those acquisitions, cost synergies resulting from the consolidation or elimination of certain functions, and intangible assets that do not qualify for separate recognition such as the assembled workforce of each acquisition.
Supplemental Pro Forma Data (Unaudited)
Citiwaste’s financial results since the date of the acquisition have been included in our consolidated financial results for the years ended
June 30, 2018
and
2017
. The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data):
|
|
|
|
|
|
Twelve-Months Ended
|
|
June 30, 2016
|
|
|
Revenues
|
$
|
36,306
|
|
Net loss
|
$
|
(159
|
)
|
Weighted average common shares outstanding
|
15,861
|
|
Net loss per common share basic and diluted
|
$
|
(0.01
|
)
|
NOTE 13 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)
The following tables show quarterly financial information for the years ended
June 30, 2018
and
2017
. The Company believes that all necessary adjustments have been included in the amounts below to present fairly the results of such periods (in thousands expect per share amounts).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
September 30,
2017
|
|
December 31,
2017
|
|
March 31,
2018
|
|
June 30,
2018
|
Total revenues
|
$
|
9,683
|
|
|
$
|
11,119
|
|
|
$
|
9,427
|
|
|
$
|
9,912
|
|
Gross profit
|
$
|
3,028
|
|
|
$
|
3,131
|
|
|
$
|
2,296
|
|
|
$
|
2,947
|
|
Operating income (loss)
|
$
|
101
|
|
|
$
|
107
|
|
|
$
|
(707
|
)
|
|
$
|
(78
|
)
|
Net income (loss)
|
$
|
75
|
|
|
$
|
156
|
|
|
$
|
(757
|
)
|
|
$
|
(146
|
)
|
Net income (loss) per share - basic and diluted
|
$
|
0.00
|
|
|
$
|
0.01
|
|
|
$
|
(0.05
|
)
|
|
$
|
(0.01
|
)
|
Weighted average shares - diluted
|
16,093
|
|
|
16,068
|
|
|
16,082
|
|
|
16,082
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
September 30,
2016
|
|
December 31,
2016
|
|
March 31,
2017
|
|
June 30,
2017
|
Total revenues
|
$
|
9,531
|
|
|
$
|
9,707
|
|
|
$
|
8,588
|
|
|
$
|
10,362
|
|
Gross profit
|
$
|
2,959
|
|
|
$
|
2,895
|
|
|
$
|
2,352
|
|
|
$
|
3,631
|
|
Operating income (loss)
|
$
|
(940
|
)
|
|
$
|
(204
|
)
|
|
$
|
(638
|
)
|
|
$
|
595
|
|
Net income (loss)
|
$
|
(967
|
)
|
|
$
|
(227
|
)
|
|
$
|
(668
|
)
|
|
$
|
569
|
|
Net income (loss) per share - basic and diluted
|
$
|
(0.06
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
0.04
|
|
Weighted average shares - diluted
|
15,868
|
|
|
15,929
|
|
|
15,994
|
|
|
16,029
|
|
Sharps Compliance (NASDAQ:SMED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sharps Compliance (NASDAQ:SMED)
Historical Stock Chart
From Jul 2023 to Jul 2024